GlassScriptPhysician profile
Dana Mckee
NPI 1699138248
$7,477.59
in general payments reported to CMS, 2019-2025
23 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $92.91 · 2022: $1,234 · 2023: $5,416 · 2024: $299 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $2,270 · Travel and Lodging: $881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $2,269.62 |
| Travel and Lodging | $880.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,380.01 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Applied Medical Resources Corporation | $922.20 | 2023 | Gelpoint V-Path |
| Gynesonics, INC. | $496.64 | 2022-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Hologic Sales and Service, LLC | $284.54 | 2023-2024 | Acessa Provu System |
| Coloplast Corp | $186.08 | 2023-2024 | Altis |
| Olympus America INC. | $169.13 | 2023-2025 | Olympus, Olympus |
| Sumitomo Pharma America, INC. | $160.09 | 2023-2024 | Myfembree |
| Channel Medsystems, INC. | $135.75 | 2023 | |
| Meditrina | $126.60 | 2025 | |
| Novo Nordisk INC | $94.84 | 2023-2025 | Wegovy |
| Momentis Surgical INC. | $92.91 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $72.57 | 2022-2023 | |
| Caldera Medical, INC | $67.20 | 2024 | Desara |
| Mayne Pharma Commercial LLC | $52.95 | 2023 | |
| Exact Sciences Corporation | $50.06 | 2025 | Cologuard Collection Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $36.46 | 2022 | |
| Lilly USA, LLC | $36.23 | 2025 | Mounjaro, Zepbound |
| Vertex Pharmaceuticals Incorporated | $23.75 | 2025 | |
| Axonics, INC. | $23.41 | 2023 | Axonics |
| Shield Therapeutics INC | $21.51 | 2023 | Accrufer |
| Aspira Women'S Health INC | $17.21 | 2022 | |
| Astellas Pharma US INC | $14.71 | 2025 | Veozah |
| Agile Therapeutics, INC. | $12.74 | 2023 | Twirla |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Mckee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.